Please assess the completion status of the following clinical trial:

Trial Title: Continuous Glucose Monitoring Initiation at Hospital Discharge

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. 18 years of age or older~2. Have diabetes (type 1 diabetes mellitus, type 2 diabetes mellitus, cystic fibrosis related diabetes mellitus)~3. Hemoglobin A1c greater than or equal to 8.0% or history of hypoglycemia unawareness~4. Able and willing to sign informed consent form~5. Have a valid telephone number~6. Willing to purchase FreeStyle Libre 2 CGM sensors out of pocket after discharge from hospital (when insurance coverage isn't available)~Exclusion Criteria:~1. Unable to sign informed consent form~2. Have altered mental status~3. Unable to manage diabetes independently at home~4. Have utilized CGM in the past~5. Pregnancy~6. New steroid-induced hyperglycemia~7. Unwilling to participate in the study~8. Have kidney disease requiring hemodialysis~9. Taking high doses of vitamin C daily (greater than 500 mg every day)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CGM Intervention (Type: EXPERIMENTAL): All eligible patients will receive a Continuous Glucose Monitor (CGM) prior to hospital discharge after signing an informed consent.

Based on this trial design, predict the completion outcome and termination type (if applicable).